Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for awake neuromodulation system implantation
NL-OMON41067Phase 2Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of dexmedetomidine, sponsored by Erasmus MC. Primary endpoint: Overall patient satisfaction. Started Sep 2014; status: active, not recruiting.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on NL-OMON41067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41067.